140 related articles for article (PubMed ID: 2884124)
21. Intrathecal dynorphins suppress hindlimb electromyographic activity in rats.
Stevens CW; Weinger MB; Yaksh TL
Eur J Pharmacol; 1987 Jun; 138(2):299-302. PubMed ID: 2887441
[TBL] [Abstract][Full Text] [Related]
22. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
23. DynorphinA-(2-17) restores spinal/supraspinal morphine synergy in morphine-tolerant mice.
He L; Lee NM
J Pharmacol Exp Ther; 1997 Mar; 280(3):1210-4. PubMed ID: 9067305
[TBL] [Abstract][Full Text] [Related]
24. Effect of dynorphin-(1-13) and related peptides on respiratory rate and morphine-induced respiratory rate depression.
Woo SK; Tulunay FC; Loh HH; Lee NM
Eur J Pharmacol; 1983 Dec; 96(1-2):117-22. PubMed ID: 6662192
[TBL] [Abstract][Full Text] [Related]
25. Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration.
Green PG; Lee NM
Eur J Pharmacol; 1988 Jan; 145(3):267-72. PubMed ID: 2895003
[TBL] [Abstract][Full Text] [Related]
26. The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
Rattan AK; Koo KL; Tejwani GA; Bhargava HN
Brain Res; 1992 Jul; 584(1-2):207-12. PubMed ID: 1355391
[TBL] [Abstract][Full Text] [Related]
27. Stereospecific effects of a kappa-opiate antagonist on the actions of morphine in morphine-tolerant rats.
Bhargava HN; Kremer EK; Gibbons MO; Philips BJ; Driver JW; Chou M
Eur J Pharmacol; 1989 Dec; 173(2-3):159-64. PubMed ID: 2560431
[TBL] [Abstract][Full Text] [Related]
28. Intracerebroventricular morphine produces diuresis 24 h after previous dynorphin/morphine treatment.
Hong O; Young GA; Khazan N
Eur J Pharmacol; 1986 Dec; 132(1):83-5. PubMed ID: 2880730
[TBL] [Abstract][Full Text] [Related]
29. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice.
Takemori AE; Loh HH; Lee NM
Eur J Pharmacol; 1992 Oct; 221(2-3):223-6. PubMed ID: 1358653
[TBL] [Abstract][Full Text] [Related]
30. Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in rats.
Pentel PR; Wananukul W; Hooke LP; Jones CR; Hatsukami D; Anderson WR; Lee NM
Pharmacol Biochem Behav; 1995; 51(2-3):387-90. PubMed ID: 7667358
[TBL] [Abstract][Full Text] [Related]
31. Aconitum-Derived Bulleyaconitine A Exhibits Antihypersensitivity Through Direct Stimulating Dynorphin A Expression in Spinal Microglia.
Li TF; Fan H; Wang YX
J Pain; 2016 May; 17(5):530-48. PubMed ID: 26762790
[TBL] [Abstract][Full Text] [Related]
32. A diminution of delta9-tetrahydrocannabinol modulation of dynorphin A-(1-17) in conjunction with tolerance development.
Mason DJ; Lowe J; Welch SP
Eur J Pharmacol; 1999 Sep; 381(2-3):105-11. PubMed ID: 10554877
[TBL] [Abstract][Full Text] [Related]
33. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
34. Is tolerance to intrathecal morphine in intact rats supraspinally mediated?
Advokat C; Magoun J
Pharmacol Biochem Behav; 1991 Jul; 39(3):761-3. PubMed ID: 1784605
[TBL] [Abstract][Full Text] [Related]
35. Dynorphin: important mediator for electroacupuncture analgesia in the spinal cord of the rabbit.
Han JS; Xie GX
Pain; 1984 Apr; 18(4):367-376. PubMed ID: 6145139
[TBL] [Abstract][Full Text] [Related]
36. Antinociception and paralysis induced by intrathecal dynorphin A.
Herman BH; Goldstein A
J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity to morphine-evoked bradycardia in rats is modified by dynorphin (1-13), Leu- and Met-enkephalin.
Kiang JG; Wei ET
J Pharmacol Exp Ther; 1984 May; 229(2):469-73. PubMed ID: 6716269
[TBL] [Abstract][Full Text] [Related]
38. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents.
Randich A; Thurston CL; Ludwig PS; Timmerman MR; Gebhart GF
Brain Res; 1991 Mar; 543(2):256-70. PubMed ID: 2059834
[TBL] [Abstract][Full Text] [Related]
39. Lack of tolerance and morphine-induced cross-tolerance to the analgesia of chimeric peptide of Met-enkephalin and FMRFa.
Gupta K; Vats ID; Gupta YK; Saleem K; Pasha S
Peptides; 2008 Dec; 29(12):2266-75. PubMed ID: 18930087
[TBL] [Abstract][Full Text] [Related]
40. Characterization of dynorphin A-induced antinociception at spinal level.
Spampinato S; Candeletti S
Eur J Pharmacol; 1985 Mar; 110(1):21-30. PubMed ID: 2861098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
